Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5447)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through May 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dreyer C, Sablin MP, Bouattour M, Neuzillet C, Ronot M, Dokmak S, Belghiti J, Guedj N, Paradis V, Raymond E, Faivre S. Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy. World J Hepatol 2015; 7(6): 910-915 [PMID: 25937868 DOI: 10.4254/wjh.v7.i6.910] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i6/910.htm |
| Number | Citing Articles |
| 1 |
Suthipong Chujan, Tawit Suriyo, Teerapat Ungtrakul, Yotsawat Pomyen, Jutamaad Satayavivad. Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis. Biomedical Reports 2018; doi: 10.3892/br.2018.1101
|
| 2 |
Valeria Simone, Oronzo Brunetti, Luigi Lupo, Mario Testini, Eugenio Maiorano, Michele Simone, Vito Longo, Christian Rolfo, Marc Peeters, Aldo Scarpa, Amalia Azzariti, Antonio Russo, Domenico Ribatti, Nicola Silvestris. Targeting Angiogenesis in Biliary Tract Cancers: An Open Option. International Journal of Molecular Sciences 2017; 18(2): 418 doi: 10.3390/ijms18020418
|
| 3 |
Yue Wang, Tianli Chen, Kangshuai Li, Wentao Mu, Zengli Liu, Anda Shi, Jialiang Liu, Wei Zhao, Shuo Lian, Shaohui Huang, Chang Pan, Zongli Zhang. Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.777617
|
| 4 |
Richard A. Burkhart, Daniel A. Laheru, Joseph M. Herman, Timothy M. Pawlik. Multidisciplinary management and the future of treatment in cholangiocarcinoma. Expert Opinion on Orphan Drugs 2016; 4(3): 255 doi: 10.1517/21678707.2016.1130618
|
| 5 |
Rachna T Shroff, Mark Yarchoan, Ashley O'Connor, Denise Gallagher, Marianna L Zahurak, Gary Rosner, Chimela Ohaji, Susan Sartorius-Mergenthaler, Vivek Subbiah, Ralph Zinner, Nilofer S Azad. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. British Journal of Cancer 2017; 116(11): 1402 doi: 10.1038/bjc.2017.119
|
| 6 |
Adriana Romanzi, Erica Villa. Angiogenesis: the Yin and Yang in intrahepatic cholangiocarcinoma. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.53
|